- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2373-8057
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Genetically-informed prediction of short-term Parkinson’s disease progression ; volume:8 ; number:1 ; day:28 ; month:10 ; year:2022 ; pages:1-11 ; date:12.2022
npj Parkinson's Disease ; 8, Heft 1 (28.10.2022), 1-11, 12.2022
- Creator
-
Sadaei, Hossein J.
Cordova-Palomera, Aldo
Lee, Jonghun
Padmanabhan, Jaya
Chen, Shang-Fu
Wineinger, Nathan E.
Dias, Raquel
Prilutsky, Daria
Szalma, Sandor
Torkamani, Ali
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41531-022-00412-w
- URN
-
urn:nbn:de:101:1-2023011320593085696407
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:26 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Sadaei, Hossein J.
- Cordova-Palomera, Aldo
- Lee, Jonghun
- Padmanabhan, Jaya
- Chen, Shang-Fu
- Wineinger, Nathan E.
- Dias, Raquel
- Prilutsky, Daria
- Szalma, Sandor
- Torkamani, Ali
- SpringerLink (Online service)
Other Objects (12)
Prevention of progression in Parkinson’s disease
Short-term temporal memory in idiopathic and Parkin-associated Parkinson’s disease
The Personalized Parkinson Project: examining disease progression through broad biomarkers in early Parkinson’s disease
Does the MDS-UPDRS provide the precision to assess progression in early Parkinson’s disease? Learnings from the Parkinson’s progression marker initiative cohort
Evaluating a motor progression connectivity model across Parkinson’s disease stages
Simulating the progression of brain structural alterations in Parkinson’s disease
Initiation and progression of α-synuclein pathology in Parkinson’s disease
Predictors of short-term anxiety outcome in subthalamic stimulation for Parkinson’s disease
Genetically engineered mesenchymal stem cells with dopamine synthesis for Parkinson’s disease in animal models
Self-report data as a tool for subtype identification in genetically-defined Parkinson’s Disease
Disease progression strikingly differs in research and real-world Parkinson’s populations
Prasinezumab slows motor progression in rapidly progressing early-stage Parkinson’s disease
Prevention of progression in Parkinson’s disease
Short-term temporal memory in idiopathic and Parkin-associated Parkinson’s disease
The Personalized Parkinson Project: examining disease progression through broad biomarkers in early Parkinson’s disease
Does the MDS-UPDRS provide the precision to assess progression in early Parkinson’s disease? Learnings from the Parkinson’s progression marker initiative cohort
Evaluating a motor progression connectivity model across Parkinson’s disease stages
Simulating the progression of brain structural alterations in Parkinson’s disease
Initiation and progression of α-synuclein pathology in Parkinson’s disease
Predictors of short-term anxiety outcome in subthalamic stimulation for Parkinson’s disease
Genetically engineered mesenchymal stem cells with dopamine synthesis for Parkinson’s disease in animal models
Self-report data as a tool for subtype identification in genetically-defined Parkinson’s Disease
Disease progression strikingly differs in research and real-world Parkinson’s populations
Prasinezumab slows motor progression in rapidly progressing early-stage Parkinson’s disease
Prevention of progression in Parkinson’s disease
Short-term temporal memory in idiopathic and Parkin-associated Parkinson’s disease
The Personalized Parkinson Project: examining disease progression through broad biomarkers in early Parkinson’s disease
Does the MDS-UPDRS provide the precision to assess progression in early Parkinson’s disease? Learnings from the Parkinson’s progression marker initiative cohort
Evaluating a motor progression connectivity model across Parkinson’s disease stages
Simulating the progression of brain structural alterations in Parkinson’s disease
Initiation and progression of α-synuclein pathology in Parkinson’s disease
Predictors of short-term anxiety outcome in subthalamic stimulation for Parkinson’s disease
Genetically engineered mesenchymal stem cells with dopamine synthesis for Parkinson’s disease in animal models
Self-report data as a tool for subtype identification in genetically-defined Parkinson’s Disease
Disease progression strikingly differs in research and real-world Parkinson’s populations